Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry

Tomáš Büchler,Zbyněk Bortlíček,Karel Hejduk,Bohuslav Melichar,Petra Pokorná,Z. Linke,Luboš Petruželka,Jindrich Finek,Jana Prausová,Katerina Kubackova

Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry

2016

Tomáš Büchler
Zbyněk Bortlíček
Karel Hejduk
Bohuslav Melichar
Petra Pokorná
Z. Linke
Luboš Petruželka
Jindrich Finek
Jana Prausová
Katerina Kubackova

Objective To describe the use of regorafenib for the treatment of metastatic colorectal cancer (mCRC) in clinical practice in the Czech Republic, and to describe the clinical outcomes of patients in terms of safety and survival.

Keywords:

Clinical Practice
Bevacizumab
Cetuximab
Medicine
Czech
Rheumatoid arthritis
Colorectal cancer
Regorafenib
Pathology
Sorafenib
Physical therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations